New Discoveries in Cancer and Heart Disease
MCED PATENTS
Following an 8 year review process by the U.S. patent office, Dr. Weisenthal was awarded patents on virtually all aspects of MCED, including pharmacodiagnostic tests he developed that detect its presence in individuals. The interventional target itself is patented also, affording protection to biopharmaceutical partners wishing to develop MCED-targeted drug therapies.
The following are U.S. patents. These are of great importance to potential collaborators seeking to commercialize the work. Historically, commercialization has been the fastest means of bringing the benefits of new medical discoveries to the public.
Method to detect endothelial cell massive calcium accumulation death
Patent number: 8623613
Abstract: Stains that are specific for calcium ion are used to assess and predict the effects of various treatments on the viability of cell types contained in a sample, wherein said stain detects endothelial cells that have massive calcium accumulation death.
Type: Granted
Filed: April 13, 2011
Issued: January 7, 2014
Inventor: Larry M. Weisenthal
Link to patent online:
http://www.google.com/patents/US8623613
Efficient well being assessment and improved treatment protocol
Abstract: Methods to appraise general health and to assess the effectiveness of therapeutic agents are disclosed. These methods can be performed on blood samples or other bodily fluids and comprise effecting cell death of endothelial cells, staining the dead cells and observing them microscopically. In addition, the invention is directed to combination treatments for neoplastic diseases or other conditions characterized by unwanted angiogenesis by administering an antiangiogenesis agent while maintaining nontoxic levels of ethanol and/or DMSO in the blood.
Type: Granted
Filed: May 22, 2009
Issued: October 2, 2012
Inventor: Larry M. Weisenthal
Link to patent online:
http://www.google.com/patents/US8278033
Microaggregates including endothelial cells
Patent number: 8192949
Abstract: Microaggregates which mimic the native environment of cells contained in biopsied tissue are used to assess and predict the effects of various treatments on the viability of cell types contained in the microaggregate.
Type: Granted
Filed: December 15, 2006
Issued: June 5, 2012
Inventor: Larry M. Weisenthal
Link to patent Online:
http://www.google.com/patents/US8192949